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Abstract
In  this  paper we present the clinical  observation of  successful  treatment of  distal  form of
peripheral artery disease of the lower extremity with symptoms of critical ischemia in a 60 years
old patient. Intramuscular injection of dual expression plasmid, encoding vascular endothelial
growth factor VEGF and basic fibroblast growth factor FGF2, was performed to the affected
lower extremity. The effect of treatment was evaluated by functional tests: measurement of
ankle-brachial index, treadmill test, the recovery time, shoulder-ankle index after strain and
temporary occlusion. Performed immunohistochemical examination of biopsy samples of the
affected lower extremity muscles.
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